NCT07803679: A Trial Assessing the Effectiveness of Evolocumab in Reducing the Plaque Burden in Participants With Subclinical Atheroma
- State
- Not started
- Phase
- Phase 4
- People
- 308 planned
- Started
- 31 Jan 2027
- Primary completion
- 30 Apr 2029
- Arms
- Evolocumab and Routine Lipid Management
- Results
- None posted
- 4 Sep 2026: Trial registered